Statins differ significantly in their anti-inflammatory activity

Journal of the American Academy of Dermatology

Volumn 65, Issue 6, 2011, Pages 1229-

  Kwatra, Shawn G ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN;

ANTIINFLAMMATORY ACTIVITY; CYTOKINE PRODUCTION; DISEASE ASSOCIATION; DRUG EXPOSURE; HUMAN; LETTER; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PSORIASIS; RISK REDUCTION;

FEMALE; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; HYPOLIPIDEMIC AGENTS; MALE; PSORIASIS;

EID: 81155124210     PISSN: 01909622     EISSN: 10976787     Source Type: Journal    
DOI: 10.1016/j.jaad.2011.07.042     Document Type: Letter

References (2)

1. Y.B. Brauchli, S.S. Jick, and C.R. Meier Statin use and risk of first-time psoriasis diagnosis J Am Acad Dermatol 65 2011 77 83
2. A. Hilgendorff, H. Muth, B. Parviz, A. Staubitz, W. Haberbosch, and H. Tillmanns Statins differ in their ability to block NF-kappaB activation in human blood monocytes Int J Clin Pharmacol Ther 41 2003 397 401 (Pubitemid 37138482)